IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Conference
IQVIA Publishes its 2023 Environmental, Social and Governance Report
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
Biopharma R&D spending rebounded in 2023, up $11 billion from 2022 following a steep post-pandemic decline. But the number of new clinical trial starts slowed to levels from before the Covid-19 pandemic, the data and services firm IQVIA said in a new report.
IQVIA CFO Ron Bruehlman to Speak at Citi's Unplugged Medtech Access Day
IQVIA quarterly results beat estimates on strong demand for research services
IQVIA Named to Fortune® World's Most Admired Companies™ List
IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
Global Medicine Spending to Reach $2.3 Trillion by 2028